[1] 中华医学会肝病学分会脂肪肝和酒精性肝病学组. 酒精性肝病诊疗指南（2010年修订版）. 中华肝脏病杂志,2010,18（3）：167-170.
[2] Stinson FS,Grant BF,Dufour MC. The critical dimension of ethnicity in liver cirrhosis mortality statistics. Alcohol Clin Exp Res,2001,25（8）：1181-1187.
[3] Goldman D,Oroszi G,Ducci F. The genetics of addictions： uncovering the genes. Nat Rev Genet,2005,6（7）：521-532.
[4] Warner LA,White HR,Johnson V. Alcohol initiation experiences and family history of alcoholism as predictors of problem-drinking trajectories. J Stud Alcohol Drugs,2007,68（1）：56-65.
[5] Edenberg HJ,Dick DM,Xuei X,et al. Variations in GABRA2,encoding the alpha 2 subunit of the GABA（A）receptor, are associated with alcohol dependence and with brain oscillations. Am J Hum Genet,2004,74（4）：705-714.
[6] Reich T,Edenberg HJ,Goate A,et al. Genome-wide search for genes affecting the risk for alcohol dependence. Am J Med Genet,1998,81（3）：207-215.
[7] Crabb DW,Matsumoto M,Chang D,et al. Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and theirvariants in the genesis of alcohol-related pathology. Proc Nutr Soc,2004,63（1）：49-63.
[8] Zintzaras E,Stefanidis I,Santos M,et al. Do alcohol-metabolizing gene polymorphisms increase the risk of alcoholism and alcoholic liver disease?Hepatology,2006,43（2）：352-361.
[9] Homann N,Stickel F,Konig IR,et al. The alcohol dehydrogenase 1C*1 allele is a genetic marker for alcohol-associated cancer in heavy drinkers. Int J Cancer,2006,118（8）：1998-2002.
[10] Evans RM,Barish GD,Wang YX. PPARs and the complex journey to obesity. Nat Med,2004,10（4）：355-361.
[11] Rey JW,Noetel A,Hardt A,et al. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor g2 in patients with fatty liver diseases. World J Gastroenterol,2010,16（46）：5830-5837.
[12] Frenzer A,Butler WJ,Norton ID,et al. Polymorphism in alcohol-metabolizing enzymes,glutathione S-transferases and apolipoprotein E and susceptibility to alcohol-induced cirrhosis and chronic pancreatitis. J Gastroenterol Hepatol,2002,17（2）：177-182.
[13] Mandrekar P,Szabo G. Signalling pathways in alcohol-induced liver inflammation. J Hepatol,2009,50（6）：1258-1266.
[14] Jarvelainen HA,Orpana A,Perola M,et al. Promoter polymorphism of the CD14 endotoxin receptor gene as a risk factor for alcoholic liver disease. Hepatology,2001,33（5）：1148-1153.
[15] Stickel F,Osterreicher CH,Halangk J,et al. No role of matrix metalloproteinase-3 genetic promoter polymorphism as a risk factor for cirrhosis in alcoholic liver disease. Alcohol Clin Exp Res,2008,32（6）：959-965.
[16] Osterreicher CH,Halangk J,Berg T,et al. Evaluation of the transforming growth factor beta-1 codon 25 （Arg/Pro） polymorphism in alcoholic liver disease. Cytokine,2008,42（1）：18-23.
[17] Sookoian S,Pirola CJ. Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene（PNPLA3）on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology,2011,53（6）：1883-1894.
[18] Tian C,Stokowski RP,Kershenobich D,et al. Variant in PNPLA3 is associated with alcoholic liver disease. Nat Genet,2010,42（1）：21-23.
[19] Seth D,Daly AK,Haber PS,et al. Patatin-like phospholipase domain containing 3：a case in point linking genetic susceptibility for alcoholic and nonalcoholic liver disease. Hepatology,2010,51（4）：1463-1465.
[20] Trepo E,Gustot T,Degre D,et al. Common polymorphism in the PNPLA3/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease. J Hepatol,2011,55（4）：906-912.
[21] Stickel F,Buch S,Lau K,et al. Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians.Hepatology,2011,53（1）：86-95.
[22] Huang Y,He S,Li JZ,et al. A feed-forward loop amplifies nutritional regulations of PNPLA3. Proc Natl Acad Sci USA,2010,107（17）：7892-7897.
[23] Basantani MK,Sitnick MT,Cai L,et al. Pnpla3/adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome. J Lipid Res,2011,52（2）：318-329.
[24] Trepo E,Pradat P,Potthoff A,et al. Impact of patatin-like phospholipase-3（rs738409 C>G） polymorphism on fibrosis progression and steatosis in chronic hepatitis C. Hepatology,2011,54（1）：60-69.
[25] Baulande S,Lasnier F,Lucas M,et al. Adiponutrin,a transmembrane protein corresponding to a novel dietary- and obesity-linked mRNA specifically expressed in the adipose lineage. J Biol Chem,2001,276（36）：33336-33344.
（校对：陈从新） |
